A new drug-releasing system, TAR-200, eliminated tumours in 82% of patients in a phase 2 clinical trial for individuals with high-risk...
Vous n'êtes pas connecté
Rubriques :
- DRUGS.COM - Daily MedNews - 18/Aug 10:08
Device Eliminates Bladder Cancers in 4 of 5 Cases
MONDAY, Aug. 18, 2025 — A new implant eliminated bladder cancer in more than 4 out of 5 high-risk cases, new clinical trial results show. The miniature pretzel-shaped device, dubbed TAR-200, slowly releases the chemotherapy drug gemcitabine...
Articles similaires
New slow-release bladder cancer treatment clears tumors in 82% of patients
knowridge.com - 17/Aug 00:06
A new drug delivery system has shown remarkable success in treating a common form of bladder cancer that had stopped responding to standard therapies....
New slow-release bladder cancer treatment clears tumors in 82% of patients
knowridge.com - 17/Aug 00:06
A new drug delivery system has shown remarkable success in treating a common form of bladder cancer that had stopped responding to standard therapies....
New slow-release bladder cancer treatment clears tumors in 82% of patients
knowridge.com - 20/Aug 00:32
A new drug delivery system has shown remarkable success in treating a common form of bladder cancer that had stopped responding to standard therapies....
New slow-release bladder cancer treatment clears tumors in 82% of patients
knowridge.com - 20/Aug 00:32
A new drug delivery system has shown remarkable success in treating a common form of bladder cancer that had stopped responding to standard therapies....
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
drugs.com - 21/Aug 15:08
THURSDAY, Aug. 21, 2025 -- For patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC),...
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
drugs.com - 21/Aug 15:08
THURSDAY, Aug. 21, 2025 -- For patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC),...
New Means Found For Treating Blood Staph Infections with IV Dalbavancin
drugs.com - 14/Aug 10:08
THURSDAY, Aug. 14, 2025 — A new way to battle bloodborne staph infections could help save lives while combating the rise of antibiotic-resistant...
New Means Found For Treating Blood Staph Infections with IV Dalbavancin
drugs.com - 14/Aug 10:08
THURSDAY, Aug. 14, 2025 — A new way to battle bloodborne staph infections could help save lives while combating the rise of antibiotic-resistant...
New Brain Implant Could Let People Speak Just by Thinking Words
drugs.com - 15/Aug 14:08
FRIDAY, Aug. 15, 2025 — For the first time, scientists have created a brain implant that can “hear” and vocalize words a person is...
Les derniers communiqués
-
Hanwha announces $5 billion Philly Shipyard investment as part of S. Korea's commitment to U.S. shipbuilding growth
Hanwha Group - 27/08/2025
-
QuickLogic Showcases eFPGA Hard IPs at GlobalFoundries Technology Summit
QuickLogic Corporation - 27/08/2025
-
Guidehouse Research Expects Global Market for Data Center Cooling to Surpass $40 Billion by 2034
Guidehouse - 27/08/2025
-
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
Rosen Law Firm - 26/08/2025
-
Global Digital Biomarkers Market Anticipating Remarkable Growth at a CAGR of ~17% by 2032 | DelveInsight
DelveInsight Business Research, LLP - 26/08/2025
-
Consumer Watchdog Joins Amicus Brief To Protect Consumers' Privacy And Keep California Courthouse Doors Open
Consumer Watchdog - 26/08/2025
-
Secretary Noem announces an additional $28 million to support North Carolina recovery
The Department of homeland security - 24/08/2025
-
NASA's Webb telescope discovers new moon orbiting Uranus
National Aeronautics and Space Administration - 22/08/2025
-
InventHelp Inventor Develops New Winter Hose Accessory (SGM-543)
Inventhelp - 22/08/2025
-
Netskope Files Registration Statement for Proposed Initial Public Offering
Netskope - 22/08/2025